Shares of Telesis Bio, Inc. (NASDAQ:TBIO) rose sharply in today’s pre-market trading session after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis. Telesis Bio reached a new partnership with laboratory automation and innovation company Beckman Coulter Life Sciences to create efficient and scalable biofoundries and deliversolutions for DNA synthesis. Telesis Bio shares jumped 109.9% to $4.87 in the pre-market trading. Here are some other stocks moving in pre-market trading. GainersKintara Therapeutics, Inc. (NASDAQ:KTRA) rose 41.8% …